Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial
Published Online: 2019-10-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Amado Zurita•Ana M Aparicio•Christopher J Logothetis•Eleni Efstathiou•Elisabeth I Heath•Elsa Li-Ning-Tapia•Emi Sei•Jennifer Wang•Lianchun Xiao•Naveen Ramesh•Nicholas Navin•Patricia Troncoso•Paul G Corn•Shi-Ming Tu•Sumit K Subudhi•Timothy C Thompson•Xuemei Wang
